We screened a total of 112 compounds (Supplementary Table 9) and found that CHEMBL348436 (also known as Cirsimaritin) has the potential to regulate blood leukocyte pyroptosis in COVID-19 patients while simultaneously improving prognosis through FOS and NFKB1A inhibition. The gene discussed is FOS; the disease is COVID-19.